These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37505778)

  • 1. Prognostic Value of Plasma miR-29a Evaluation in Chronic Lymphocytic Leukemia Patients.
    Aref S; El Tantawy A; Aref M; El Agdar M; Ayed M
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2439-2444. PubMed ID: 37505778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Serum CD200 Concentrations in Chronic Lymphocytic Leukemia.
    Aref S; El Tantawy A; Gouda E; Ayed M
    Asian Pac J Cancer Prev; 2023 Jun; 24(6):1943-1948. PubMed ID: 37378922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study.
    Casabonne D; Benavente Y; Seifert J; Costas L; Armesto M; Arestin M; Besson C; Hosnijeh FS; Duell EJ; Weiderpass E; Masala G; Kaaks R; Canzian F; Chirlaque MD; Perduca V; Mancini FR; Pala V; Trichopoulou A; Karakatsani A; La Vecchia C; Sánchez MJ; Tumino R; Gunter MJ; Amiano P; Panico S; Sacerdote C; Schmidt JA; Boeing H; Schulze MB; Barricarte A; Riboli E; Olsen A; Tjønneland A; Vermeulen R; Nieters A; Lawrie CH; de Sanjosé S
    Int J Cancer; 2020 Sep; 147(5):1315-1324. PubMed ID: 32012253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis.
    Papageorgiou SG; Kontos CK; Diamantopoulos MA; Bouchla A; Glezou E; Bazani E; Pappa V; Scorilas A
    Dis Markers; 2017; 2017():2046545. PubMed ID: 29463948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of microRNA Profile as a Molecular Biomarker in Egyptian Chronic Lymphocytic Leukemia.
    Farahat NMG; Elkaffash DMNED; Alghandour AH; Swelem RS; Abo El-Wafa RAH
    Indian J Hematol Blood Transfus; 2019 Jan; 35(1):89-99. PubMed ID: 30828154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Expression Profile of miR-27b, miR-29a, and miR-155 in Chronic Lymphocytic Leukemia and Breast Cancer Patients.
    Raeisi F; Mahmoudi E; Dehghani-Samani M; Hosseini SSE; Ghahfarrokhi AM; Arshi A; Forghanparast K; Ghazanfari S
    Mol Ther Oncolytics; 2020 Mar; 16():230-237. PubMed ID: 32123723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and Prognostic Value of MiR-155 in Patients with Chronic Lymphocytic Leukemia].
    Wang F; Xu W; Gu WY; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):34-39. PubMed ID: 32027250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value of Plasma miR-145 and miR-185 as Targeting of the APRIL Oncogene in the B-cell Chronic Lymphocytic Leukemia.
    Bagheri M; Khansarinejad B; Mosayebi G; Moradabadi A; Mondanizadeh M
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):111-117. PubMed ID: 33507687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
    Yang YQ; Tian T; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Wang L; Fan L; Li JY; Xu W
    BMC Cancer; 2018 Oct; 18(1):1009. PubMed ID: 30348117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of the miR-17~92 Cluster in Chronic Lymphocytic Leukemia.
    Chocholska S; Zarobkiewicz M; Szymańska A; Lehman N; Woś J; Bojarska-Junak A
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
    Zhu DX; Zhu W; Fang C; Fan L; Zou ZJ; Wang YH; Liu P; Hong M; Miao KR; Liu P; Xu W; Li JY
    Carcinogenesis; 2012 Jul; 33(7):1294-301. PubMed ID: 22610076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of miR-29a expression in pediatric acute myeloid leukemia.
    Zhu C; Wang Y; Kuai W; Sun X; Chen H; Hong Z
    Clin Biochem; 2013 Jan; 46(1-2):49-53. PubMed ID: 22981932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia.
    Papageorgiou SG; Kontos CK; Tsiakanikas P; Stavroulaki G; Bouchla A; Vasilatou D; Bazani E; Lazarakou A; Scorilas A; Pappa V
    Leuk Res; 2018 Jul; 70():1-7. PubMed ID: 29715621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of microRNA 17-92 cluster expression in Egyptian chronic lymphocytic leukemia patients.
    Khalifa MM; Zaki NE; Nazier AA; Moussa MA; Haleem RA; Rabie MA; Mansour AR
    J Egypt Natl Canc Inst; 2021 Dec; 33(1):37. PubMed ID: 34866170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The expression and prognostic significance of microRNA-34a in Uygur and Han patients with chronic lymphocytic leukemia in Xinjiang Uygur Autonomous Region in China].
    Liu H; Wang XM; Mao M; Fu L; Huang Q; Wang YL; Wang YC; Wang ZS; Li Y
    Zhonghua Nei Ke Za Zhi; 2018 Dec; 57(12):922-925. PubMed ID: 30486562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic Leukemia.
    Stamatopoulos B; Van Damme M; Crompot E; Dessars B; Housni HE; Mineur P; Meuleman N; Bron D; Lagneaux L
    Mol Med; 2015 Jan; 21(1):123-33. PubMed ID: 25584781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
    Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS
    Mol Cancer; 2013 Dec; 12():173. PubMed ID: 24373626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
    Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
    Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Karyotype-specific microRNA signature in chronic lymphocytic leukemia.
    Visone R; Rassenti LZ; Veronese A; Taccioli C; Costinean S; Aguda BD; Volinia S; Ferracin M; Palatini J; Balatti V; Alder H; Negrini M; Kipps TJ; Croce CM
    Blood; 2009 Oct; 114(18):3872-9. PubMed ID: 19717645
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Habashy DM; Eissa DS; Aboelez MM
    Turk J Haematol; 2018 Aug; 35(3):168-174. PubMed ID: 28884705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.